DNA GENTECH INC Com New

Ownership history in CAXTON ASSOCIATES LP  ·  18 quarters on record

This page tracks every 13F SEC filing in which CAXTON ASSOCIATES LP reported a position in GENTECH INC Com New (DNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.29% (2006 Q1)
Avg. % of fund
0.1%
First filed
1999 Q4
Last filed
2024 Q3
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 REDUCED 59,415 -317,993 -84.3% 0.02% $484K $8.15
2024 Q1 ADDED 377,408 +369,087 +4435.6% 0.02% $438K $46.40
2009 Q1 REDUCED 8,321 -41,679 -83.4% 0.07% $790K
2008 Q3 REDUCED 50,000 -14,800 -22.8% 0.20% $4.4M
2008 Q1 REDUCED 64,800 -35,200 -35.2% 0.09% $5.3M
2007 Q3 ADDED 100,000 +81,790 +449.1% 0.17% $7.8M
2007 Q2 REDUCED 18,210 -62,707 -77.5% 0.01% $1.4M
2006 Q2 REDUCED 80,917 -366,666 -81.9% 0.05% $6.6M
2006 Q1 ADDED 447,583 +412,654 +1181.4% 0.29% $37.8M
2005 Q4 REDUCED 34,929 -200,944 -85.2% 0.02% $3.2M
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DNA price (monthly, adj. close)
← Back to CAXTON ASSOCIATES LP Holdings